chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 22-year-old patient with colitis ulcerative who was vaccinated with MMR which was required to work in a hospital. Concomitant therapy included immunosuppressive therapy (unspecified). Unspecified medical attention was sought. Subsequently, the patient experienced a negative measles titer. Additional information has been requested.
2/13 1230 am. Sever pain in left arm at injection site 1:00pm chills body aches fatigue 2:00pm  fever 102 Went to bed at 6pm with all symptoms. Woke up at 430 am on 2/14 and felt better
Itchy; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy) and VACCINATION SITE PAIN (pain at the injection site) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history provided by the reporter.  Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN).    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site). On 10-Jan-2021, the patient experienced PRURITUS (Itchy). On 07-Jan-2021, VACCINATION SITE PAIN (pain at the injection site) outcome was unknown. At the time of the report, PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant lab data were reported. No medical treatment was reported.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Hives onset 4-5 hours after vaccine. Stomach pain, cough and eye swelling.
Patient received 2nd dose of Pfizer Pediatric dose on 10/01/2022 Lot FL2757. Product removal update on 10/25/2022 for Lot FL2757
A non-serious spontaneous report of patient received expired FLUMIST was received from a health professional concerning a six-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 20-Feb-2011. On 25-Feb-2011, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
RECEIVED MULTIPLE COVID-19 VACCINES AS FOLLOWS: 3/25/2021: MODERNA #008B21A 4/20/2021: PFIZER #ER8729 5/11/2021: PFIZER #EW0175
That night, patient reports not being able to bend arm, very sore, hives, burning/freezing feeling at the same time, weakness, exhaustion, lots of pain. Only self treated with TYLENOL. She showed her doctor her arm today and he mentioned hives but did not suggest any treatment. She does not report having any issues breathing. She did mention that she sensitive to many medications and hives are common for her.
I went to give this man a High dose Fluzone in left deltoid and when I stuck the needle in his arm the vaccine vial broke away from the needle and the vaccine squirted all over my gloved hand. It broke away from the needle at the part where the needle screws into the vial and this round piece also fell off. I pulled the needle immediately out of his arm and re-administered vaccine with new vial and different needle.
trunk w/urticarial rash 18hr p/vax;prescribed DPH  until rash subsided;
patient in the  monitoring facility post vaccination with possible allergic reaction with reported tongue swelling. Monitoring team called. Patient then had seizure. Transported to ED.
Stiff neck; baseball size lump; hard, hot, red baseball size lump; Itching at the site; red baseball size lump; hot; Arm mildly sore; Neck pain; Back pain; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain), BACK PAIN (Back pain), VACCINATION SITE WARMTH (hot) and MUSCULOSKELETAL STIFFNESS (Stiff neck) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic back pain and Neck pain.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain) and BACK PAIN (Back pain). On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot), VACCINATION SITE MASS (baseball size lump), VACCINATION SITE INDURATION (hard, hot, red baseball size lump), VACCINATION SITE PRURITUS (Itching at the site) and VACCINATION SITE ERYTHEMA (red baseball size lump). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff neck). At the time of the report, PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain), BACK PAIN (Back pain), VACCINATION SITE WARMTH (hot), MUSCULOSKELETAL STIFFNESS (Stiff neck), VACCINATION SITE MASS (baseball size lump), VACCINATION SITE INDURATION (hard, hot, red baseball size lump), VACCINATION SITE PRURITUS (Itching at the site) and VACCINATION SITE ERYTHEMA (red baseball size lump) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.    This case was linked to MOD-2021-077018 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: The patient details, vaccine information and event outcome were updated.
body aches, headache; headache; This is a spontaneous report from a contactable consumer. A female patient of unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 27Mar2021 as a single dose for COVID-19 immunisation. Medical history was not reported and the patient did not have a history of allergies to any food or medications or other products. The patient did not receive any other medications within two weeks of the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 06Mar2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, on the day after the second shot for about 8-12 hours, the patient experienced body aches and headache. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event body aches and headache was recovered on unknown date in Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Onset of longitudinally extensive transverse myelitis and subsequent diagnosis of anti-AQP4 neuromyelitis optica approximately 2 months after the bivalent pfizer vaccine
10 days after - Developed bumps at injection site. Itchy, red, swollen, warm to touch.  The itching went away but arm still swollen, red, warm. Today 9-17-21 noticed it grew much larger and has a red ring around it
crying >3hr w/in 48hr of vax;crying started on 11mAY, cried when awake, still crying 13MAY @ MD;started improving 13MAy evening;
Patient has been evaluated in the office by Dr.  for shoulder pain. He has had an xray completed. He has attended many PT appointments. Dr. is now going to refer to ortho for their evaluation.
One hour after arising, she was unable to move her right arm, and had pins and needles.  Symptoms persist intermittently.
Pt experienced excessive crying and screaming for 4 full days. Mild temperature, Used baby Tylenol drops for 4 days. After 4 days the crying stopped. She has a scab where the shot was given after 1 1/2 months on her right leg.
According to school nurse, "dime-sized" area of pain, swelling and erythema to the left posterior upper arm beginning 3/3/08.
The parent who filled out the child's consent form wrote the date of birth as but the real birthday is, meaning that the patient was 4 years of age at the time of vaccination for the 5-11 monovalent Pfizer. I spoke with the patient over the phone and let her know that the child was given a 5-11 pfizer.
1st dose 20Apr201, no 2nd dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (1st dose 20Apr201, no 2nd dose yet) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (1st dose 20Apr201, no 2nd dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (1st dose 20Apr201, no 2nd dose yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products was provided by the reporter. No treatment information was provided by the reporter.   Reporter did not allow further contact
Moderna COVID-19 Vaccine EUA  Sudden dramatic hearing loss in right ear. ENT said internal, ?mechanically? my ear is fine. Starting on steroids for viral infection.
1.  One hour after injection severe tinnitus (bilateral) which has persisted 2.  FIve hours after injection arm swelling and mod-severe pain at injection site - resolving after 3 days but left with low grade pain 3. Seven hours after injection developed moderate headache, fever to 101 F, and shaking chills that lasted about 4-5 hours, generalized achiness, mod-severe fatigue 4. #1 has persisted, with varying intensity 5. #3 chills stopped after 4-5 hours, took tylenol twice to relieve fever Have persistent low-grade headache 6.  I have a photo, injection has given very medially near tendon, remains tender with decreased ROM
11/6 - left thigh becomes slightly numb - increases over next week 11/14 - 11/20 - lower back pain and cramping in left thigh - increasing discomfort through week 11/21 - pain in back escalates, along with severe cramps in left thigh 11/22 - Dr.  - prescribed Naproxin and Methylprednisone 11/22 - 11/27 - pain continues  11/28 - pain increases  11/29 - Dr. refers me to Hospital.  Admitted 9 pm. 12/2 - released from Hospital, prescribed oxycodone and prednizone, lidocane patches 12/3 - 12/28 pain and cramping continues, gradual attentuation of back pain, pain in thigh remains
I had trouble sleeping and became very emotional. This may be unrelated to the vaccine but I thought it best to report because I had an unusual night. I called off from work today because I couldn't sleep.
Pregnancy resulted in a miscarriage; Did not receive 2nd dose; Found out she was pregnant after receiving 1st dose; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of ABORTION SPONTANEOUS (Pregnancy resulted in a miscarriage) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 22-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Found out she was pregnant after receiving 1st dose). On an unknown date, the patient experienced ABORTION SPONTANEOUS (Pregnancy resulted in a miscarriage) (seriousness criterion medically significant) and PRODUCT DOSE OMISSION ISSUE (Did not receive 2nd dose). The delivery occurred on an unknown date, which was reported as Abortion NOS. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. On 22-Mar-2021, EXPOSURE DURING PREGNANCY (Found out she was pregnant after receiving 1st dose) had resolved. At the time of the report, ABORTION SPONTANEOUS (Pregnancy resulted in a miscarriage) had resolved and PRODUCT DOSE OMISSION ISSUE (Did not receive 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  It was reported that the patient received first shot and then found out she was pregnant.  The pregnancy resulted in a miscarriage and patient wanted to knowif she should now get her 2nd shot, or restart the vaccination series.    This is a case of product exposure during pregnancy with an associated adverse event of abortion spontaneous. Based on temporal association a causal relationship cannot be excluded. Also This report refers to a case of Product dose omission. further information is not expected.   Reporter did not allow further contact; Sender's Comments: This is a case of product exposure during pregnancy with an associated adverse event of abortion spontaneous. Based on temporal association a causal relationship cannot be excluded. Also This report refers to a case of Product dose omission. further information is not expected.
Patient complained of localized burning at the site after 10 minutes, then started coughing, lost consciousness and epinephrine was administered, patient regained consciousness and was given oral diphenhydramine as well. Patient was taken to hospital by EMS, remaining outcome unknown.
Information has been received from a healthcare worker concerning an 89 year old female patient who on 09/23/2004 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 647029/0460P).  On 09/23/2004 the patient had a swollen arm.  On 09/24/2004 the patient developed a rash all over the body.  Unspecified medical attention was sought.  No product quality complaint involved.  It was reported to be unknown if this was the first or second vaccination.  It was also reported that another patient had a similar reaction.  Additional information has been requested.
brain zapps for 16 hours. arm numbing and tingling for unsaid amount of time. excruciating muscle aches and no body strength.
Skin very tender with red marks all on right side to middle of chest and around to middle of back. Very sore, painful. Was given VALTREX for 2 weeks along with prednisone. Marks started clearing up in 3rd week. Skin was still tender. At least 5 weeks before back to normal.
EXTREME FATIGUE ENLARGED TESTICLE - WAS DIRECTED TO CALL DOCTOR TO SEE IF THEY BELIEVED A VISIT WAS NECESSARY
patient reports developing "whole body hives" after 1st dose of pfizer covid vaccine.  no sensation of throat closing in.
p/vax started running 105 temp @ 11Am some day;cried for 4hr;given APAP & temp came down;
Skin rash, rash, erythema multiforme and swelling. Prednisone 40 mg every day, prednisone 20 mg every day.
Information has been received from a physician concerning a 2 and half year old male with unremarkable med history and no allergies who "about two weeks ago" on approximately 04-APR-2007 was vaccinated subcutaneously with a 0.5 ml dose of Proquad. Concomitant vaccinations included PEDIARIX and Hib conj vaccine. "About two weeks ago" approximately 04-APR-2007 the patient experienced redness and swelling at injection site. Medical attention was sought. The patient's outcome was not reported. No product quality complaint was involved. Additional information has been requested.
My daughter received her 12 month vaccinations on Wednesday morning. That night she started running a fever. (102.6 under the arm). Thursday she woke up with two large red bumps on her back, they almost looked like bug bites. Fever continued. Friday on her leg where she got a bad she had a red bump, similar to the ones on her back. I called her PCP and they said if she got more rash/bumps or higher fever to bring her in. Today, her fever spiked to 103.2 (under the arm) WITH ibuprofen and she started getting red pinpoint dots on her back and neck.  So I took her to urgent care. No bacterial infection, no UTI,  no throat spots. She does have an enlarged lymph node behind her ear. He said it was viral, and no medicine would help. Or he said it could be from the vaccinations. And to come back if it worsens and to see our PCP on Monday.  I'm guessing from my research it is vaccine related and either from Varivax or MMR.
Client was given 4 y/o shots in legs due to broken clavicle. Client had raised light pink itchy rash on stomach, legs and tops of hands starting 7 days after administration of vaccine. Client mom admits to changing laundry soap but states "we have used that kind before with no problems" Client was given Benadryl for itchy rash.
This non-serious initial spontaneous case, was received from other health professional on 27-Sep-2017, concerning a patient of unspecified age and gender. On an unspecified date, the patient was administered with FLUAD (TIV) (batch number: 179002, expiry date: unspecified date in May 2018, dose, route of administration and anatomical location: not reported). It was reported that, syringe (Luer lock) was checked for bubbles, and was injected at the patient's arm which was cleansed with alcohol swab as the plunger was pushed into the arm. The vaccine was spewed out, while the needle was still in-patient arm (explicitly coded as incomplete dose administered). It was reported that, 1 syringe was used where only half of the dose was injected, during use of the vaccine, they found that the defect was in between connection of needle and syringe. The reporter stated that, the patient had not experienced any adverse event. It was reported that, no signs of damage were seen on the syringe and needle, and the needle appeared to be tightly attached. The leaking was seen in the connection between the needle and syringe. It was reported that, the needle 25 gauge/1 inch was used. It was reported that, they didn't try to administer the vaccine with another needle as the needle was already in the patient's arm. This report was associated with PTC reference Number: 1024790. At the time of this report, the outcome of the events was not reported. Follow-up received on 10-Oct-2017: The reporter stated that, the PTC (product technical complaint) was reported without an adverse event. Narrative amended accordingly. Non-significant follow-up received on 18-Oct-2017: Batch number was updated. Amended accordingly. Non-significant case correction received on 27-Sep-2017: The PTC reference Number: 1024790 was amended in narrative.
This spontaneous case, initially received from other non-health professional on 17-Sep-2018, concerns a 61-year-old, adult female patient. The patient's medical history included lump in throat and difficulty to swallow when she had allergic reaction to eggs (unspecified date). It was reported that, later the patient had no issues while eating eggs and with other vaccines. On 17-Sep-2018, at 2:00 pm, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 252380 and expiry date: 31-May-2019]. On the same day, right after vaccination, the patient felt warmth in her neck and face. About 20 minutes after vaccination, the patient felt strange and, on the way back to home, felt throat tightness and the road before her was jumping around. The patient also had a metallic taste in the mouth and the throat was numb, like someone had sprayed antiseptic spray. The patient stated that some of these symptoms had diminished, but felt there was a lump in her throat and it was hard to swallow. At the time of this report, symptoms reduced but the patient had not recovered from the events. The reporter assessed the case as non-serious.
Erythema and warmth at site of injection about 1 week. Did treat for possible cellulitis when erythema worsened and sxs improved and then resolved.
Patient had high anxiety entering into vaccination chair. Talked at length about current data and allergy reactions. After about 10 min post dose resident reported feeling dizzy and that jaw "felt weird" . Took patients blood pressure at 11:15am - reading was 184 / mmHg and pulse was 106.  Upon further discussion jaw felt "tight" - verified with patient that it did not feel like it was closing, and that roof of mouth was tingling.  Benadryl offered, and  patient declined. She stated she would like fresh air, and went outside and took a walk with a nurse.  Blood pressure rechecked at 11:33am BP  was 188 / 111 mmHg pulse 96. Resident states that her normal BP is around 145/90.   Automatic BP checked again at 12:51pm was 188 / 112 mmHg and pulse 89. Had checked with pharmacy intern manually and reading was 166/104 mmHg. Patient stated she felt "better" jaw was ok and tingling in mouth was subsiding.   Discussed importance of calling her PCP to discuss  potential diagnosis of hypertension.
My left arm has had pain and still hurts today. It's hard to use it to dress and undress. I got a fever that would not come down and the worst heachache that felt like a migraine and I never have ever had one before, body aches, joint and muscle pain, fatigue and I couldn't stay awake , nausea, upset stomach with diarrhea within 10 or 15 minutes of getting the vaccine. It felt like a really bad flu that lasted 8 hours.
Information has been received from a healthcare worker concerning a 12 years old female patient who got her first dose of GARDASIL (dose, route and lot # not reported) on 18-JUL-2011, her second dose on 05-JUL-2012 (dose, route and lot # not reported), and her third dose of GARDASIL (dose, route and lot # not reported) on 05-SEP-2012. No adverse effects reported. Additional information has been requested.
Altered migraine, elevated Cardiolipin IgM (83, 97), possible CVA (stroke).    Sought medical treatment after altered migraine which led to discovery of brain stem lesion requiring further characterization. Currently, no diagnosis and awaiting additional testing to confirm nature of brain stem lesion.